Abpro Holdings Inc. (NASDAQ:ABP) Short Interest Update

Abpro Holdings Inc. (NASDAQ:ABP) saw a large decrease in short interest during the month of December. As of December 31st, there was short interest totaling 10,134 shares, a decrease of 46.8% from the December 15th total of 19,055 shares. Currently, 0.4% of the shares of the stock are sold short. Based on an average trading volume of 10,788 shares, the short-interest ratio is currently 0.9 days. Based on an average trading volume of 10,788 shares, the short-interest ratio is currently 0.9 days. Currently, 0.4% of the shares of the stock are sold short.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in ABP. Goldman Sachs Group Inc. acquired a new position in Abpro during the 1st quarter worth approximately $30,000. Geode Capital Management LLC raised its holdings in shares of Abpro by 127.6% in the 2nd quarter. Geode Capital Management LLC now owns 196,494 shares of the company’s stock valued at $42,000 after purchasing an additional 110,159 shares in the last quarter. Finally, Yorkville Advisors Global LP purchased a new stake in shares of Abpro during the 3rd quarter worth $192,000. Hedge funds and other institutional investors own 23.30% of the company’s stock.

Abpro Stock Performance

NASDAQ:ABP opened at $3.89 on Thursday. Abpro has a 12-month low of $3.78 and a 12-month high of $42.90. The firm has a market cap of $10.58 million, a PE ratio of -0.92 and a beta of 0.02. The stock has a fifty day moving average price of $5.39 and a 200 day moving average price of $6.21.

Abpro (NASDAQ:ABP) last posted its quarterly earnings results on Friday, November 14th. The company reported ($0.63) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.20) by $0.57.

Analyst Ratings Changes

ABP has been the subject of a number of recent research reports. Wall Street Zen downgraded Abpro to a “strong sell” rating in a research note on Saturday, November 8th. Maxim Group cut shares of Abpro from a “buy” rating to a “hold” rating in a research report on Tuesday, October 21st. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Abpro in a research note on Monday, December 29th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Abpro currently has a consensus rating of “Reduce” and a consensus target price of $120.00.

About Abpro

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.